The DOI matches its Crossref record; 53 of the 58 references it cites were found in a registry or an index.
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds
Open accessAbstract
G-quadruplex (G4)-forming genomic sequences, including telomeres, represent natural replication fork barriers. Stalled replication forks can be stabilized and restarted by homologous recombination (HR), which also repairs DNA double-strand breaks (DSBs) arising at collapsed forks. We have previously shown that HR facilitates telomere replication. Here, we demonstrate that the replication efficiency of guanine-rich (G-rich) telomeric repeats is decreased significantly in cells lacking HR. Treatment with the G4-stabilizing compound pyridostatin (PDS) increases telomere fragility in BRCA2-deficient cells, suggesting that G4 formation drives telomere instability. Remarkably, PDS reduces proliferation of HR-defective cells by inducing DSB accumulation, checkpoint activation, and deregulated G2/M progression and by enhancing the replication defect intrinsic to HR deficiency. PDS toxicity extends to HR-defective cells that have acquired olaparib resistance through loss of 53BP1 or REV7. Altogether, these results highlight the therapeutic potential of G4-stabilizing drugs to selectively eliminate HR-compromised cells and tumors, including those resistant to PARP inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This effect seems to be aggravated in cells with an impaired DNA repair machinery and deficiencies in homologous recombination. (72).”
From G-quadruplex-mediated genomic instability drives SNVs in cancer (2024) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simple technique for quantitation of low levels of DNA damage in individual cells
Singh, N. P., McCoy, M. T., Tice, R. R., & Schneider, E. L. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90265-0 · Cited by 10,828 · cited 1×
“Alkaline Single-Cell Gel Electrophoresis Comet Assay Thecometassaywasperformedaspreviouslydescribed (Singh et al., 1988).”
MethodGenomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397 · cited 1×
“Genomic instability is a hallmark of cancer caused by failure of normal DNA replication and/or repair mechanisms (Halazonetis Mo et al., 2008; Negrini et al., 2010).”
BackgroundQuantitative visualization of DNA G-quadruplex structures in human cells
Biffi, G., Tannahill, D., McCafferty, J., & Balasubramanian, S. (2013) · Nature Chemistry · doi:10.1038/nchem.1548 · Cited by 2,173 · cited 1×
“G4 structures have been subsequently detected with several other structure-specific antibodies (Biffi et al., 2013; Henderson et al., 2014; Schaffitzel et al., 2001) and interacting small molecules (Lam et al., 2013; Müller et al., 2010; Rodriguez et al., 2012).”
BackgroundCauses and consequences of replication stress
Zeman, M. K., & Cimprich, K. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2897 · Cited by 2,079 · cited 1×
“RPA accumulation on the chromatin, together with elevated frequency of origin firing and reduced replication rates, represents signatures of replicative stress (Zeman and Cimprich, 2014).”
BackgroundCrystal structure of parallel quadruplexes from human telomeric DNA
Parkinson, G., Lee, M. P. H., & Neidle, S. (2002) · Nature · doi:10.1038/nature755 · Cited by 1,863 · cited 1×
“Importantly, telomeric G-rich DNA sequences have a high propensity to adopt G4 configurations (Parkinson et al., 2002).”
BackgroundAn Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851
Prevalence of quadruplexes in the human genome
Huppert, J. L., & Balasubramanian, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki609 · Cited by 1,795 · cited 2×
“A conundrum posed by this quantificationwas that PDS induced approximately fifteen DSBs per metaphase in cells lacking RAD51, yet in silico predictions suggested thatmore than 300,000 genomic sites can adopt G4 configurations (Huppert and Balasubramanian, 2005).”
Background53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Bunting, S. F., Callén, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.012 · Cited by 1,671 · cited 4×
“…Zimmer, Eliana M.C. Tacconi, Cecilia Folio, ..., Annamaria Biroccio, Julian E. Sale, Madalena Tarsounas Correspondence madalena.tarsounas@oncology.ox.ac.uk In Brief Zimmer et al. discovered that homologous recombination activities of BRCA1 and BRCA2…”
BackgroundInfluentialHelix formation by guanylic acid.
Gellert, M., Lipsett, M., & Davies, D. R. (1962) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.48.12.2013 · Cited by 1,430 · cited 2×
“The ability of G-rich DNA to adopt G4 secondary structures in vitro was reported over 50 years ago (Gellert et al., 1962).”
BackgroundSchlacher, K., Christ, N., Siaud, N., Egashira, A., Wu, H., & Jasin, M. (2011) · Cell · doi:10.1016/j.cell.2011.03.041 · Cited by 1,292 · cited 2×
“HR factors act to stabilize stalled replication forks by preventing their nucleolytic degradation (Hashimoto et al., 2010; Schlacher et al., 2011) to restart arrested forks (Lambert et al., 2010) and to repair double-strand breaks (DSBs) arising from disintegrated forks (Aze et al., 2013).”
Background
Flagged first, then by citations
5 of the 58 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Bouwman, 2014, Molecular pathways: how can BRCA-mutated tumors become resistant to PARP inhibitors?, Clin. Cancer Res., 20, 540, 10.1158/1078-0432.CCR-13-0225 · DOI
Cited by
Sorted by citations
Items 201–231 of 231
G-quadruplex dynamics contribute to epigenetic regulation of mitochondrial functionPreprint
Falabella, M., Kolesar, J. E., Xiang, I. M., Wang, T. R. W., Horne, W. T., Wallace, C. T., Sun, L., Taguchi, Y. V., Wang, C., Turek-Herman, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/359703 · Cited by 3
“For example, small molecule G4-ligands that bind and stabilize G4 structures can induce genomic instability at sequences with high potential for G4 formation, such as the human minisatellite CEB1 (9) and telomeric DNA (10, 11).”
BackgroundG-quadruplex DNA reprograms the photochemistry of CX-5461 toward radical-driven anticancer activity
Trojnar, J., Cottini, M. V., Dudek, M., Monnereau, C., Khrouz, L., Hsueh, K.-W., Liu, Y., Huang, P.-Y., Jamroškovič, J., & Deiana, M. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag777 · Cited by 2
“Their prevalence in highly transcribed and replication-stressed genomic regions has positioned G4s as compelling therapeutic targets, particularly in cancers with defective DNA damage response (DDR) pathways [ 2–6 ].”
G‐Quadruplexes: Structural Diversity and Emerging Roles in Biomolecular Condensation
Wang, W.-M., Xu, Q.-Q., Zhang, Y.-X., Liu, F., Sui, G.-C., & Li, D.-D. (2026) · Advancement of science · doi:10.1002/advs.76663 · Cited by 1
The SMARCA4 subunit of the SWI/SNF complex prevents genome instability at G quadruplexes
Harrod, A., Feng, H., Ghaddar, N., Schiavoni, F., Lane, K. A., Wu, L., Zuazua‐Villar, P., Kozik, Z., Dobbs, F. M., van Eijk, P., et al. (2026) · Genome biology · doi:10.1186/s13059-026-04080-4 · Cited by 2
“Cells with defects in pathways important for replication stress, DNA repair, and G4 resolution show increased PDS sensitivity [17, 18].”
In silico mapping of non-canonical DNA structures across the human ribosomal DNA locus
Adala, J. D., & Knutson, B. A. (2025) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkaf299 · Cited by 1
“Both agents disrupt rRNA synthesis and induce nucleolar stress across a range of can - cer types (Drygin et al. 2011; Zimmer et al. 2016; Xu et al. 2017; Ferreira et al. 2020).”
Matmati, S., Rao, S., & Lingner, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.25.690390
“…considered as therapeutic agents to target telomeres in BRCA1 and BRCA2-mutant cancer cells that are defective in homology-directed repair (HDR) (Zimmer et al , 2016; Groelly et al , 2022; Keahi et al , 2025) and clinical trials with G-stabilizers for HDR-deficient tumors have been launched…”
InfluentialDexheimer, T. S., Coussens, N. P., Silvers, T. E., Juneja, P., Jones, E., Gore, S. D., Kunkel, M. W., Doroshow, J. H., & Teicher, B. A. (2025) · SLAS DISCOVERY · doi:10.1016/j.slasd.2025.100284 · Cited by 1
Cheng, M., Wang, R., Pang, Y., Chen, X., Zhang, J., & Zhong, C. (2025) · Tissue & Cell · doi:10.1016/j.tice.2025.103093 · Cited by 1
Lowran, K., Campbell, L., Cismas, E., & Wu, C. G. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00333 · Cited by 2
Keahi, D. L., Sanders, M. A., Paul, M., Webster, A. L., Fang, Y., Wiley, T., Shalaby, S., Carroll, T. S., Chandrasekharappa, S., Sandoval-Garcia, C., et al. (2024) · bioRxiv · doi:10.1101/2024.07.20.604431 · Cited by 1
“The connection of G4s and BRCA2 may also be important in other settings of BRCA1/2 deficiency, as the stabilization by PDS leads to cell death in BRCA1/2 deficient cells (Zimmer et al. 2016) and in patient derived xenografts (Groelly et al. 2022).”
BackgroundGroelly, F. J., Dagg, R. A., Mailler, J., Halazonetis, T., & Tarsounas, M. (2023) · STAR Protocols · doi:10.1016/j.xpro.2022.101970 · Cited by 1
Self-citation53BP1 nuclear body-marked replication stress in a human mammary cell model of BRCA2 deficiencyPreprint
Feng, W., & Jasin, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/462119 · Cited by 1
“For example, BRCA2 prevents R-loop accumulation [33, 34] and maintains the integrity of telomeres [35] and G-quadruplex-forming sites [36].”
BackgroundRNA ‐related functions of BRCA2 in transcription, replication, and genome stability
Alvaro-Aranda, L., Sridhara, S. R. C., & Carreira, A. (2026) · FEBS Letters · doi:10.1002/1873-3468.70461
Replication stress in cancer: origins, consequences and therapeutic opportunities
Chen, J., & Zou, L. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00979-z · Cited by 2
Laghari, Z. A., Li, N., Gayybov, S., Wang, Q.-E., & Chai, W.-H. (2026) · NAR Cancer · doi:10.1093/narcan/zcag023
“…analyzed RPA32 Ser33 phosphorylation (pS33) by immunofluorescence analysis, a marker of ssDNA accumulation at replication-associated lesions [ 74 , 75 ], in HU-treated PEO1 cells with or without stable STN1 overexpression, as well as in HeLa cells following BRCA2 depletion, with and without…”
Bartosik, A. R., Bujnowska, M., Stovall, D. B., Ratan, A., & Wang, Y. (2026) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2026.2710103
“Consistent with this idea, multiple studies report that PhenDC3 and CX-5461 exhibit selective toxicity in tumors lacking homologous recombination and non-homologous end-joining pathways (Zimmer et al. 2016; Xu et al. 2017; Bruno et al. 2020; Hilton et al. 2022; Jin et al. 2023).”
G-quadruplex homeostasis is a determinant of PARP inhibitor toxicity in BRCA2-deficient cells
Sharma, A. B., Krwawicz, J., Tappenden, L., Ramlee, M. K., Abugable, A. A., Zhen, X., Khurana, S., Stracker, T. H., & Lakin, N. (2026) · Nature Communications · doi:10.1038/s41467-026-75083-9
“These observations are reminiscent of the fi ndings that G4 ligands are toxic to BRCA2-de fi cient cells throughinducingreplication-associatedDNAdamage 18,19 .”
George, J. C., Kulikowicz, T., Bombard, P. T., Rossi, M., Dumm, A. J., Anderson, O. M., Sommers, J. A., & Brosh, R. M. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113214
Kciuk, M., Machura, G., Wanke, K., Smarzewska, S., Mojzych, M., Płuciennik, E., & Kontek, R. (2026) · Scientific Reports · doi:10.1038/s41598-026-52451-5
Laghari, Z. A., Li, N., Gayybov, S., Wang, Q.-E., & Chai, W.-H. (2026) · bioRxiv · doi:10.64898/2026.05.15.725290
“SsDNA gaps can arise from stalling of DNA polymerases or uncoupling of leading and lagging strand synthesis during persistent replication stress, Okazaki fragment maturation defects, PrimPol-mediated repriming downstream of DNA lesions, impaired chromatin assembly during replication stress, and…”
Chakramurty, A., Nurbaiti, N., & Ladala, E. W. (2025) · PREPOTIF : JURNAL KESEHATAN MASYARAKAT · doi:10.31004/prepotif.v9i3.50041
“Pemeriksaan fisik dilakukan secara sistematis dengan penilaian stadium perkembangan pubertas (Tanner staging) (Taylor et al., 2019).”
Suárez, B. H., Gillespie, D. A., Dejnaka, E., Obmińska‐Mrukowicz, B., & Pawlak, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209928 · Cited by 1
“These compounds stabilize G4 structures and may exert anti-cancer effect either by inducing DNA damage selectively in cancer cells or by modulating the expression of oncogenes [11–14].”
Kagalwala, Z. B., Chhipa, M. A., Kianfard, Z., Karam, E., Magalage, S. P., & Sabatinos, S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090756
“HSV1-TK is a promiscuous kinase that can phosphorylate a broad array of nucleosides including cytidine [38,40].”
Neupane, A., Chariker, J., & Rouchka, E. (2023) · bioRxiv · doi:10.1101/2023.01.30.526341
“While some ligands have shown binding affinity towards G quadruplex structures for treatment of cancer specific cells and transcriptional alteration (14), binding of other ligands that stabilize G4 lead to multiple DNA damage (14), micronuclei formation, delayed replication fork progression (15), and telomeric defects…”
Telomere Targeting Approaches in Cancer: Over the Length Maintenance.Preprint
Vertecchi, E., Rizzo, A., & Salvati, E. (2021) · Preprints.org · doi:10.20944/preprints202111.0367.v1
“Naphtalene diimmides G-quadruplex DDR activation Ionizing radiations Glioma Pancreatic cancer [109][110] [111][112] [113] Pyridostatin G-quadruplex i-motifs DDR activation BRCA1/2 mut Colon cancer Renal cancer [114][53]”
BackgroundHERC2 promotes BLM and WRN to suppress G-quadruplex DNAPreprint
Wu, W., Rokutanda, N., Takeuchi, J., Lai, Y., Maruyama, R., Togashi, Y., Nishikawa, H., Arai, N., Miyoshi, Y., Suzuki, N., et al. (2018) · bioRxiv · doi:10.1101/341420
“Importantly, G4-stabilizers are particularly toxic to BRCA-defective cells acquiring PARP inhibitor resistance [5], indicating pharmacological application exploiting G4 stabilization as a new therapeutic”
BackgroundG-quadruplex binders cause DNA damage by inducing R-loops in human cancer cells
Magis, A. D. (2016) · doi:10.6092/unibo/amsdottorato/8442
“Then, we asked whether G4 ligand-induced DNA cleavage was repaired by homologous recombination mechanisms, under our experimental conditions, as reported by other previously (Zimmer et al., 2016).”
BackgroundResultInfluentialTherapy: Targeting replication fork stalling
Alderton, G. K. (2016) · Nature Reviews. Cancer · doi:10.1038/nrc.2016.10
Homologous recombination in mammalian cells: From molecular mechanisms to pathology
Ragu, S., Matos-Rodrigues, G. E., THOMAS, M. L., & López, B. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00020-9 · Cited by 2
Systemic Therapies of Young Breast Cancer Patients at High Genetic Risk
Paluch–Shimon, S., Kaufman, B., & Evron, E. (2020) · Springer eBooks · doi:10.1007/978-3-030-24762-1_6
Metadata
- Authors
- Zimmer, J., Tacconi, E. M. C., Folio, C., Badie, S., Porru, M., Klare, K., Tumiati, M., Markkanen, E., Halder, S., Ryan, A., Jackson, S. P., Ramadan, K., Kuznetsov, S. G., Biroccio, A., Sale, J. E., & Tarsounas, M.
- Affiliations
- University of Oxford (GB)
- Instituto Nazionale Tumori Regina Elena (IT)
- University of Helsinki (FI)
- University of Cambridge (GB)
- MRC Laboratory of Molecular Biology (GB)
- Corresponding author
- Tarsounas, Madalena
- ORCID
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 61
- Issue
- 3
- Pages
- 449-460
- ISSN
- 1097-2765 (ISSN-L)
- PMC
- PMC4747901
- OpenAlex
- W2207187217
- Cited by
- 261
- References
- 58
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 32 · 2023: 28 · 2022: 22 · 2021: 37 · 2020: 33 · 2019: 25 · 2018: 16 · 2017: 22 · 2016: 9
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Molecular Cell (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Wellcome Trust (WT092096, 092096)
- Cancer Research UK (17201, 18796, S_3001, 11224)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (141197)
- Medical Research Council (MC_PC_12001/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- G-quadruplex, BRCA1, BRCA2, homologous recombination deficiency, telomere replication, telomere instability, pyridostatin, DNA damage checkpoint, G2/M transition, olaparib resistance, 53BP1, REV7, PARP inhibitor resistance, replication fork collapse
- MeSH terms
- Poly(ADP-ribose) Polymerase Inhibitors, Tumor Suppressor p53-Binding Protein 1, Aminoquinolines, Animals, Antineoplastic Agents, Dose-Response Relationship, Drug, Humans, Male, Mice, Nude, Neoplasms, Picolinic Acids, Time Factors, Transfection, Biomarkers, Tumor, Telomere, Drug Resistance, Neoplasm, BRCA1 Protein, Xenograft Model Antitumor Assays, BRCA2 Protein, RNA Interference, Tumor Burden, Intracellular Signaling Peptides and Proteins, Cell Proliferation, DNA Breaks, Double-Stranded, G-Quadruplexes, HEK293 Cells, Molecular Targeted Therapy, G2 Phase Cell Cycle Checkpoints, Mad2 Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review